title: Peritransplant monitoring of immune cell function in adult living donor liver transplantation.
abstract: OBJECTIVE
  We evaluated the clinical utility of peritransplant in vitro assays of immune cell function in adult living donor liver transplant (LDLT) recipients.
  
  
  METHODS
  In particular, we measured immune cell function, using the ImmuKnow assay, in 107 adult LDLT recipients and 200 potential living liver donors (control group) admitted to our center between July 2008 and January 2009.
  
  
  RESULTS
  In the control group, the mean proportion of T-helper/inducer cells was 36.8% ± 8.2%. The degree of immune response was strong in 12%, moderate in 77%, and low in 11%. In the study group, the degree of immune response within the first month was strong in 4.6%, moderate in 38.2%, and low in 57.2%, thus significantly lower than in the control group (P < .001). ImmuKnow results and tacrolimus levels did not show a significant correlation (r(2) = .002, P = .392). Although six patients showed biopsy-proven acute cellular rejection, none showed a strong immune response. Patients with overt infection showed a lower immune response.
  
  
  CONCLUSIONS
  These results indicate that peritransplant assessment of immune response using the ImmuKnow assay does not reliably predict the occurrence of acute rejection. Additional studies are necessary to accurately assess the clinical utility of immune response monitoring.
authors.affiliation: Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
authors.forename: S
authors.initials: S
authors.lastname: Hwang
authors.forename: K H
authors.initials: KH
authors.lastname: Kim
authors.forename: G W
authors.initials: GW
authors.lastname: Song
authors.forename: Y D
authors.initials: YD
authors.lastname: Yu
authors.forename: G C
authors.initials: GC
authors.lastname: Park
authors.forename: K W
authors.initials: KW
authors.lastname: Kim
authors.forename: N K
authors.initials: NK
authors.lastname: Choi
authors.forename: P J
authors.initials: PJ
authors.lastname: Park
authors.forename: Y I
authors.initials: YI
authors.lastname: Choi
authors.forename: D H
authors.initials: DH
authors.lastname: Jung
authors.forename: C S
authors.initials: CS
authors.lastname: Ahn
authors.forename: D B
authors.initials: DB
authors.lastname: Moon
authors.forename: T Y
authors.initials: TY
authors.lastname: Ha
authors.forename: S G
authors.initials: SG
authors.lastname: Lee
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D006509:Hepatitis B / Q000150:complications; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000601:surgery / Q000821:virology; D008107:Liver Diseases / Q000145:classification / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology*; D019520:Living Donors; D008213:Lymphocyte Activation; D008875:Middle Aged; D059035:Perioperative Period; D011184:Postoperative Period; D012016:Reference Values; D013601:T-Lymphocytes / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
chemical_list: D007166:Immunosuppressive Agents; D000255:Adenosine Triphosphate